Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?

Clin Res Cardiol. 2007 Apr;96(4):193-5. doi: 10.1007/s00392-007-0487-y. Epub 2007 Feb 15.

Authors

Iwan C C van der Horst¹, Adriaan A Voors, Dirk J van Veldhuisen

Affiliation

¹ Thoraxcenter, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiac Output, Low / drug therapy*
Cardiac Output, Low / physiopathology
Chronic Disease
Death, Sudden, Cardiac / etiology
Death, Sudden, Cardiac / prevention & control*
Drug Therapy, Combination
Eplerenone
Humans
Mineralocorticoid Receptor Antagonists / adverse effects
Mineralocorticoid Receptor Antagonists / therapeutic use*
Myocardial Infarction / complications*
Renin-Angiotensin System / drug effects*
Spironolactone / analogs & derivatives
Spironolactone / therapeutic use
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists
Spironolactone
Eplerenone